China CAS:83-43-2 Manufacturer

We believe in: Innovation is our soul and spirit. Quality is our life. Shopper need is our God for CAS:83-43-2, our products have good reputation from the world as its most competive price and our most advantage of after-sale service to the clients。
CAS:83-43-2, we've got complete material production line, assembling line , quality control system, and the most importantly, we have many patents technology and experienced technical&production team, specialist sales service team. With all these advantages, we are gonna create"the reputable international brand of nylon monofilaments", and spreading our goods to every corner of the world. We have been keep moving and try our best to serve our customers.

Hot Products

  • Mifepristone

    Mifepristone

    Mifepristone has specifications of CP and IP. DMF and GMP approved.

    CAS:84371-65-3

  • DHEA (Prasterone)

    DHEA (Prasterone)

    DHEA (Prasterone) has FP and In-house specification. DMF and WC available.

    CAS:53-43-0

  • Pregnenolone Acetate

    Pregnenolone Acetate

    Pregnenolone Acetate

    CAS:1778-02-5

  • DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate)

    DHEA Acetate(Prasterone Acetate) is the intermediate of DHEA(prasterone).

    CAS:853-23-6

  • Mifepristone Capsules

    Mifepristone Capsules

    Mifepristone Capsules Specifications:10mg*1
    Indications:Emergency Contraceptive
  • Abiraterone

    Abiraterone

    Abiraterone is a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor (CYP17), It is used in combination with prednisone to treat patients with metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has already spread to other parts of the body) and metastatic high-risk castration-sensitive prostate cancer.

    CAS:154229-19-3

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept